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DrGent and colleagues are to be commended for performing the
first prospective, randomized study involving subfascial endoscopic
perforator surgery (SEPS). Unfortunately, this study cannot resolve
the controversy regarding whether SEPS is beneficial. In this article,
SEPS was frequently not a stand-alone surgery, but was combined
with superficial surgery in 51 of 91 limbs, and 40 of 91 limbs had had
previous superficial vein surgery performed. Only 11 patients had
isolated perforator vein incompetence. Thus, this study, as pointed
out in the title, is really a comparisonbetweennonsurgical and surgical
treatment. A few previous articles have indicated that venous surgery
shortens the time to heal and decreases the recurrence rate of ulcer-
ated limbs. This study found, disappointingly, no statistical differences
in the healing rate, ulcer recurrence rate, or ulcer-free period. Thus,
surgery was not beneficial for this group of patients. By stratifying the
material, the results indicate that a subgroup with medial and/or
recurrent ulcers would perhaps benefit from surgery. Perhaps a mul-
tivariate Cox model test would have shed further light on different
parameters.
As secondary end points, the healing rate and the ulcer recur-
rence–free rate analyzed ad modum Kaplan-Meier were used.
These are appropriate methods according to the reporting stan-
dards. To use the “ulcer-free” period is questionable. It includes
time to heal and time to ulcer recurrence, but it is also much
dependent on the length of observation and on deaths among theFrom serial studies of ulcerated limbs treated by SEPS, we
know that ulcer recurrence is lower in limbs with primary reflux as
compared with those with postthrombotic disease. It is a pity that
this material is not described by the CEAP classification, which
would better inform the reader of the composition of the patient
material. We know that deep vein reflux was present in about half
of each group, but was it segmental or axial, primary or secondary?
A history of deep vein thrombosis was found in one third of
patients, but how many had findings supporting postthrombotic
changes? Many in the surgically treated group had had previous
surgery. Had limbs randomized to conservative treatment had any
previous interventions? Perhaps there were significant discrepan-
cies in some of these aspects, and this may help explain the lack of
difference in outcome. There is no information of the status of the
perforators before and after SEPS, and this supports that the
procedure was not adequately performed.
Thus, the controversy continues regarding the importance of
perforators and their treatment. SEPS has presently largely been
replaced by ultrasound-guided sclerotherapy and laser or radiofre-
quency ablation of the perforators and is mostly used only as a last
resort. This article suggests that limbs with medial and/or recur-
rent ulcer with no superficial reflux (previously operated on or not)
may benefit from SEPS, and these limbs may be the objective of a
future prospective study.
